Skip to content

    Recently Viewed


      The Monster and the Scientists

      Share Article
      share to

      As he looks at a three dimensional computer model of a molecule that has consumed him for months, Hans describes the virus with great respect as a monster, the monster:

      “This little monster is responsible for the infection, and this structure shows us how it can infect and how it can multiply. We’re talking about diseases that can just travel. It’s gets in your body, and it easily attaches itself to you.”

      Hanneke has been obsessed with how viruses work since she was in college.

      “I thought, this is something that needs to be solved. We need to understand, how can a virus make people so ill? I was fascinated.”

      Maria, Benoit; they are leaders of global teams having great impact on HIV, Ebola, TB, and a virus called RSV that is one of the most common killers of young children.

      Hans Langedijk.
      Hanneke Schuitemaker.
      Maria Grazia Pau.
      Benoit Callendret.

      They change the perception of what you expect to see of a scientist. They are all scientists at Johnson & Johnson, yet none of these people work in a lab. Their tools are computer models and data. They begin after the lab work is completed, embracing the discovery or the breakthrough and charging forward to make that discovery a real vaccine that can save a life.

      Success here is proving it works and getting it into the world on a scale that changes the course of history, that saves communities and families.

      Yet they don’t think of their work in that way. They don’t put faces on the disease, even though when in conversation the human impact is clearly understood.

      It’s as if thinking of the child living or dying based on their success or failure is too much to process. It wouldn’t allow them to focus on the work.

      And so the work is done, and progress is made, one click, one conference call, one advance, one clinical trial, one moment of perseverance or luck. Anything that gets them, and us, closer to the goal.

      More from Johnson & Johnson

      Blue latex-gloved hands holding a beaker filled with yellow liquid

      IBD rates are rising in communities of color. Can these innovators help?

      Scientists aren’t sure what’s behind the upward trend. That’s why Johnson & Johnson Innovation put out the call to address this troubling health disparity.
      Health & wellness
      Health worker participating in the Johnson and Johnson single-use device recycling program
      Health & wellness

      3 ways Johnson & Johnson is helping make healthcare more sustainable

      Climate change is intertwined with just about every industry worldwide, including healthcare. Here, a look at how Johnson & Johnson is taking action to help support a healthy planet.
      DNA illustration genetic material

      Harnessing the human genome is the future of healthcare—and Johnson & Johnson is helping lead the way

      The company’s partnership with the largest human genome sequencing project in the world will increase scientists’ understanding of genetic diseases and help create new interventions. Here, a look at the breakthroughs that have guided the understanding of the power of DNA.
      You are now leaving and going to a site with a different privacy policy. Please click below to continue to that site.